AU5230199A - Melanocortin-4 receptor gene and use as a genetic marker for fat content, weight gain, and/or feed consumption of animals - Google Patents
Melanocortin-4 receptor gene and use as a genetic marker for fat content, weight gain, and/or feed consumption of animals Download PDFInfo
- Publication number
- AU5230199A AU5230199A AU52301/99A AU5230199A AU5230199A AU 5230199 A AU5230199 A AU 5230199A AU 52301/99 A AU52301/99 A AU 52301/99A AU 5230199 A AU5230199 A AU 5230199A AU 5230199 A AU5230199 A AU 5230199A
- Authority
- AU
- Australia
- Prior art keywords
- mc4r
- seq
- gene
- polymorphism
- oligonucleotide
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 241001465754 Metazoa Species 0.000 title claims description 61
- 239000003550 marker Substances 0.000 title claims description 33
- 230000002068 genetic effect Effects 0.000 title claims description 28
- 108010021436 Type 4 Melanocortin Receptor Proteins 0.000 title description 86
- 230000004584 weight gain Effects 0.000 title description 2
- 235000019786 weight gain Nutrition 0.000 title description 2
- 108700028369 Alleles Proteins 0.000 claims description 58
- 238000000034 method Methods 0.000 claims description 50
- 101150110867 MC4R gene Proteins 0.000 claims description 43
- 108090000623 proteins and genes Proteins 0.000 claims description 41
- 230000012010 growth Effects 0.000 claims description 37
- 108020004414 DNA Proteins 0.000 claims description 25
- 239000012634 fragment Substances 0.000 claims description 25
- 239000002773 nucleotide Substances 0.000 claims description 22
- 125000003729 nucleotide group Chemical group 0.000 claims description 22
- 238000004458 analytical method Methods 0.000 claims description 19
- 235000021050 feed intake Nutrition 0.000 claims description 17
- 238000007894 restriction fragment length polymorphism technique Methods 0.000 claims description 17
- 108091034117 Oligonucleotide Proteins 0.000 claims description 15
- 230000029087 digestion Effects 0.000 claims description 12
- 101000978418 Homo sapiens Melanocortin receptor 4 Proteins 0.000 claims description 11
- 238000009395 breeding Methods 0.000 claims description 10
- 230000001488 breeding effect Effects 0.000 claims description 9
- UYTPUPDQBNUYGX-UHFFFAOYSA-N guanine Chemical compound O=C1NC(N)=NC2=C1N=CN2 UYTPUPDQBNUYGX-UHFFFAOYSA-N 0.000 claims description 8
- 230000002503 metabolic effect Effects 0.000 claims description 8
- 239000003153 chemical reaction reagent Substances 0.000 claims description 7
- 108091008146 restriction endonucleases Proteins 0.000 claims description 7
- 230000002441 reversible effect Effects 0.000 claims description 7
- 230000003321 amplification Effects 0.000 claims description 5
- 238000003199 nucleic acid amplification method Methods 0.000 claims description 5
- 229930024421 Adenine Natural products 0.000 claims description 4
- GFFGJBXGBJISGV-UHFFFAOYSA-N Adenine Chemical compound NC1=NC=NC2=C1N=CN2 GFFGJBXGBJISGV-UHFFFAOYSA-N 0.000 claims description 4
- 229960000643 adenine Drugs 0.000 claims description 4
- 108010014303 DNA-directed DNA polymerase Proteins 0.000 claims description 2
- 102000016928 DNA-directed DNA polymerase Human genes 0.000 claims description 2
- 108091027305 Heteroduplex Proteins 0.000 claims description 2
- 238000003935 denaturing gradient gel electrophoresis Methods 0.000 claims description 2
- 102100023724 Melanocortin receptor 4 Human genes 0.000 claims 5
- 108020004707 nucleic acids Proteins 0.000 claims 3
- 150000007523 nucleic acids Chemical class 0.000 claims 3
- 102000039446 nucleic acids Human genes 0.000 claims 3
- 238000000123 temperature gradient gel electrophoresis Methods 0.000 claims 2
- JLCPHMBAVCMARE-UHFFFAOYSA-N [3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-hydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methyl [5-(6-aminopurin-9-yl)-2-(hydroxymethyl)oxolan-3-yl] hydrogen phosphate Polymers Cc1cn(C2CC(OP(O)(=O)OCC3OC(CC3OP(O)(=O)OCC3OC(CC3O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c3nc(N)[nH]c4=O)C(COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3CO)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cc(C)c(=O)[nH]c3=O)n3cc(C)c(=O)[nH]c3=O)n3ccc(N)nc3=O)n3cc(C)c(=O)[nH]c3=O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)O2)c(=O)[nH]c1=O JLCPHMBAVCMARE-UHFFFAOYSA-N 0.000 claims 1
- 102000008316 Type 4 Melanocortin Receptor Human genes 0.000 description 82
- 238000003752 polymerase chain reaction Methods 0.000 description 39
- 241000282898 Sus scrofa Species 0.000 description 34
- 230000035772 mutation Effects 0.000 description 27
- 241000282887 Suidae Species 0.000 description 26
- 239000000047 product Substances 0.000 description 26
- 208000008589 Obesity Diseases 0.000 description 20
- 235000020824 obesity Nutrition 0.000 description 20
- 102000004378 Melanocortin Receptors Human genes 0.000 description 19
- 108090000950 Melanocortin Receptors Proteins 0.000 description 19
- 238000012360 testing method Methods 0.000 description 18
- 150000001413 amino acids Chemical class 0.000 description 17
- 230000000694 effects Effects 0.000 description 15
- 239000000523 sample Substances 0.000 description 13
- 235000001014 amino acid Nutrition 0.000 description 12
- 229940024606 amino acid Drugs 0.000 description 11
- 238000013507 mapping Methods 0.000 description 11
- 238000003556 assay Methods 0.000 description 10
- 238000006243 chemical reaction Methods 0.000 description 10
- 210000000349 chromosome Anatomy 0.000 description 9
- 238000001514 detection method Methods 0.000 description 9
- 102000003688 G-Protein-Coupled Receptors Human genes 0.000 description 8
- 108090000045 G-Protein-Coupled Receptors Proteins 0.000 description 8
- 108010092277 Leptin Proteins 0.000 description 8
- 108020003175 receptors Proteins 0.000 description 8
- 108020004705 Codon Proteins 0.000 description 7
- 210000004027 cell Anatomy 0.000 description 7
- 238000004519 manufacturing process Methods 0.000 description 7
- 102000005962 receptors Human genes 0.000 description 7
- 241000282412 Homo Species 0.000 description 6
- DCXYFEDJOCDNAF-REOHCLBHSA-N L-asparagine Chemical compound OC(=O)[C@@H](N)CC(N)=O DCXYFEDJOCDNAF-REOHCLBHSA-N 0.000 description 6
- CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 description 6
- 102000016267 Leptin Human genes 0.000 description 6
- 241000699670 Mus sp. Species 0.000 description 6
- 230000008859 change Effects 0.000 description 6
- 229940039781 leptin Drugs 0.000 description 6
- NRYBAZVQPHGZNS-ZSOCWYAHSA-N leptin Chemical compound O=C([C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC=1C2=CC=CC=C2NC=1)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)CNC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](N)CC(C)C)CCSC)N1CCC[C@H]1C(=O)NCC(=O)N[C@@H](CS)C(O)=O NRYBAZVQPHGZNS-ZSOCWYAHSA-N 0.000 description 6
- 108010019813 leptin receptors Proteins 0.000 description 6
- 239000000203 mixture Substances 0.000 description 6
- 238000010369 molecular cloning Methods 0.000 description 6
- 108010056545 swine leukocyte antigen Proteins 0.000 description 6
- DCXYFEDJOCDNAF-UHFFFAOYSA-N Asparagine Natural products OC(=O)C(N)CC(N)=O DCXYFEDJOCDNAF-UHFFFAOYSA-N 0.000 description 5
- 102100031775 Leptin receptor Human genes 0.000 description 5
- 241000255969 Pieris brassicae Species 0.000 description 5
- 101100129533 Sus scrofa MC4R gene Proteins 0.000 description 5
- 108010006785 Taq Polymerase Proteins 0.000 description 5
- 229960001230 asparagine Drugs 0.000 description 5
- 235000009582 asparagine Nutrition 0.000 description 5
- 235000003704 aspartic acid Nutrition 0.000 description 5
- OQFSQFPPLPISGP-UHFFFAOYSA-N beta-carboxyaspartic acid Natural products OC(=O)C(N)C(C(O)=O)C(O)=O OQFSQFPPLPISGP-UHFFFAOYSA-N 0.000 description 5
- 230000033228 biological regulation Effects 0.000 description 5
- 239000000975 dye Substances 0.000 description 5
- 235000019197 fats Nutrition 0.000 description 5
- 230000011664 signaling Effects 0.000 description 5
- 238000013459 approach Methods 0.000 description 4
- 230000000052 comparative effect Effects 0.000 description 4
- 230000037406 food intake Effects 0.000 description 4
- 235000012631 food intake Nutrition 0.000 description 4
- 230000037433 frameshift Effects 0.000 description 4
- 235000013372 meat Nutrition 0.000 description 4
- 238000012163 sequencing technique Methods 0.000 description 4
- 241000894007 species Species 0.000 description 4
- 238000006467 substitution reaction Methods 0.000 description 4
- 208000011580 syndromic disease Diseases 0.000 description 4
- 102000006822 Agouti Signaling Protein Human genes 0.000 description 3
- 108010072151 Agouti Signaling Protein Proteins 0.000 description 3
- 102000004190 Enzymes Human genes 0.000 description 3
- 108090000790 Enzymes Proteins 0.000 description 3
- 108700005089 MHC Class I Genes Proteins 0.000 description 3
- 108010000410 MSH receptor Proteins 0.000 description 3
- 108010008364 Melanocortins Proteins 0.000 description 3
- 241000699666 Mus <mouse, genus> Species 0.000 description 3
- 238000012408 PCR amplification Methods 0.000 description 3
- 239000011543 agarose gel Substances 0.000 description 3
- 238000010171 animal model Methods 0.000 description 3
- 239000005557 antagonist Substances 0.000 description 3
- 230000008901 benefit Effects 0.000 description 3
- 230000037396 body weight Effects 0.000 description 3
- 238000012512 characterization method Methods 0.000 description 3
- 239000002299 complementary DNA Substances 0.000 description 3
- 238000001962 electrophoresis Methods 0.000 description 3
- 238000002474 experimental method Methods 0.000 description 3
- 231100000221 frame shift mutation induction Toxicity 0.000 description 3
- 239000000499 gel Substances 0.000 description 3
- 238000003205 genotyping method Methods 0.000 description 3
- 102000057094 human MC4R Human genes 0.000 description 3
- 238000009396 hybridization Methods 0.000 description 3
- 230000003993 interaction Effects 0.000 description 3
- 244000144972 livestock Species 0.000 description 3
- 230000004807 localization Effects 0.000 description 3
- 238000005259 measurement Methods 0.000 description 3
- 235000013622 meat product Nutrition 0.000 description 3
- 239000002865 melanocortin Substances 0.000 description 3
- 239000003147 molecular marker Substances 0.000 description 3
- 230000001956 orexigenic effect Effects 0.000 description 3
- 230000003234 polygenic effect Effects 0.000 description 3
- 102000004196 processed proteins & peptides Human genes 0.000 description 3
- 108090000765 processed proteins & peptides Proteins 0.000 description 3
- 210000001519 tissue Anatomy 0.000 description 3
- SNBCLPGEMZEWLU-QXFUBDJGSA-N 2-chloro-n-[[(2r,3s,5r)-3-hydroxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methyl]acetamide Chemical compound O=C1NC(=O)C(C)=CN1[C@@H]1O[C@H](CNC(=O)CCl)[C@@H](O)C1 SNBCLPGEMZEWLU-QXFUBDJGSA-N 0.000 description 2
- 241000484025 Cuniculus Species 0.000 description 2
- 206010071602 Genetic polymorphism Diseases 0.000 description 2
- 108700018351 Major Histocompatibility Complex Proteins 0.000 description 2
- 108010088565 Melanocortin 5 receptor Proteins 0.000 description 2
- 102100034216 Melanocyte-stimulating hormone receptor Human genes 0.000 description 2
- 102000003979 Mineralocorticoid Receptors Human genes 0.000 description 2
- 108090000375 Mineralocorticoid Receptors Proteins 0.000 description 2
- 108091028043 Nucleic acid sequence Proteins 0.000 description 2
- 108020005187 Oligonucleotide Probes Proteins 0.000 description 2
- 102100033912 Retinoic acid receptor gamma Human genes 0.000 description 2
- 102100038246 Retinol-binding protein 4 Human genes 0.000 description 2
- 101710137011 Retinol-binding protein 4 Proteins 0.000 description 2
- 108010000134 Vascular Cell Adhesion Molecule-1 Proteins 0.000 description 2
- 102100023543 Vascular cell adhesion protein 1 Human genes 0.000 description 2
- 239000000654 additive Substances 0.000 description 2
- 230000036528 appetite Effects 0.000 description 2
- 235000019789 appetite Nutrition 0.000 description 2
- 210000004369 blood Anatomy 0.000 description 2
- 239000008280 blood Substances 0.000 description 2
- 210000004556 brain Anatomy 0.000 description 2
- 210000003169 central nervous system Anatomy 0.000 description 2
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 2
- 230000002759 chromosomal effect Effects 0.000 description 2
- 238000003776 cleavage reaction Methods 0.000 description 2
- 238000010367 cloning Methods 0.000 description 2
- 238000004891 communication Methods 0.000 description 2
- 230000000295 complement effect Effects 0.000 description 2
- 230000001276 controlling effect Effects 0.000 description 2
- 230000000875 corresponding effect Effects 0.000 description 2
- 238000011161 development Methods 0.000 description 2
- 230000018109 developmental process Effects 0.000 description 2
- 230000019439 energy homeostasis Effects 0.000 description 2
- 230000002349 favourable effect Effects 0.000 description 2
- 210000003917 human chromosome Anatomy 0.000 description 2
- 230000006872 improvement Effects 0.000 description 2
- 230000002779 inactivation Effects 0.000 description 2
- 208000037493 inherited obesity Diseases 0.000 description 2
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 2
- 238000011835 investigation Methods 0.000 description 2
- 230000007774 longterm Effects 0.000 description 2
- 235000004213 low-fat Nutrition 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 230000001404 mediated effect Effects 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 238000006452 multicomponent reaction Methods 0.000 description 2
- 239000002751 oligonucleotide probe Substances 0.000 description 2
- 230000037361 pathway Effects 0.000 description 2
- 238000011056 performance test Methods 0.000 description 2
- 102000054765 polymorphisms of proteins Human genes 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 230000000171 quenching effect Effects 0.000 description 2
- 108010030587 rat melanocortin receptor type 4 Proteins 0.000 description 2
- 230000006798 recombination Effects 0.000 description 2
- 238000005215 recombination Methods 0.000 description 2
- 230000004044 response Effects 0.000 description 2
- 108091008760 retinoic acid receptors γ Proteins 0.000 description 2
- 150000003839 salts Chemical class 0.000 description 2
- 230000007017 scission Effects 0.000 description 2
- 238000005204 segregation Methods 0.000 description 2
- 238000010561 standard procedure Methods 0.000 description 2
- 230000007704 transition Effects 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- 235000019737 Animal fat Nutrition 0.000 description 1
- 101100334009 Caenorhabditis elegans rib-2 gene Proteins 0.000 description 1
- 102100032539 Calpain-3 Human genes 0.000 description 1
- 208000024172 Cardiovascular disease Diseases 0.000 description 1
- 241001155433 Centrarchus macropterus Species 0.000 description 1
- 108091026890 Coding region Proteins 0.000 description 1
- 238000007400 DNA extraction Methods 0.000 description 1
- 102100028071 Fibroblast growth factor 7 Human genes 0.000 description 1
- 108090000385 Fibroblast growth factor 7 Proteins 0.000 description 1
- 108091006027 G proteins Proteins 0.000 description 1
- 102000030782 GTP binding Human genes 0.000 description 1
- 108091000058 GTP-Binding Proteins 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 108010051696 Growth Hormone Proteins 0.000 description 1
- 101000867715 Homo sapiens Calpain-3 Proteins 0.000 description 1
- 101001134060 Homo sapiens Melanocyte-stimulating hormone receptor Proteins 0.000 description 1
- 101100102448 Homo sapiens VCAM1 gene Proteins 0.000 description 1
- 102000004877 Insulin Human genes 0.000 description 1
- 108090001061 Insulin Proteins 0.000 description 1
- 241000272168 Laridae Species 0.000 description 1
- 229940126661 MC4 antagonist Drugs 0.000 description 1
- 108010018650 MEF2 Transcription Factors Proteins 0.000 description 1
- 102000043129 MHC class I family Human genes 0.000 description 1
- 108091054437 MHC class I family Proteins 0.000 description 1
- 241000124008 Mammalia Species 0.000 description 1
- 102000030612 Melanocortin 5 receptor Human genes 0.000 description 1
- 102220585316 Melanocortin receptor 5_D298N_mutation Human genes 0.000 description 1
- 108010007013 Melanocyte-Stimulating Hormones Proteins 0.000 description 1
- 101710151321 Melanostatin Proteins 0.000 description 1
- 102100021148 Myocyte-specific enhancer factor 2A Human genes 0.000 description 1
- 108060008487 Myosin Proteins 0.000 description 1
- 102000003505 Myosin Human genes 0.000 description 1
- 102400000064 Neuropeptide Y Human genes 0.000 description 1
- 108020004485 Nonsense Codon Proteins 0.000 description 1
- 101710163270 Nuclease Proteins 0.000 description 1
- 229910019142 PO4 Inorganic materials 0.000 description 1
- 108010057464 Prolactin Proteins 0.000 description 1
- 102100024819 Prolactin Human genes 0.000 description 1
- 241000283984 Rodentia Species 0.000 description 1
- 238000012300 Sequence Analysis Methods 0.000 description 1
- 102100038803 Somatotropin Human genes 0.000 description 1
- 101000882572 Sus scrofa Estrogen receptor Proteins 0.000 description 1
- 101001123445 Sus scrofa Prolactin receptor Proteins 0.000 description 1
- 208000017413 Taqi polymorphism Diseases 0.000 description 1
- 108700019146 Transgenes Proteins 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 230000000996 additive effect Effects 0.000 description 1
- 210000000577 adipose tissue Anatomy 0.000 description 1
- 238000000246 agarose gel electrophoresis Methods 0.000 description 1
- 125000000539 amino acid group Chemical group 0.000 description 1
- 238000000540 analysis of variance Methods 0.000 description 1
- 238000003975 animal breeding Methods 0.000 description 1
- 230000001539 anorectic effect Effects 0.000 description 1
- 230000008485 antagonism Effects 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 235000006708 antioxidants Nutrition 0.000 description 1
- 230000003190 augmentative effect Effects 0.000 description 1
- 230000002567 autonomic effect Effects 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- 230000004071 biological effect Effects 0.000 description 1
- 210000002459 blastocyst Anatomy 0.000 description 1
- 230000001413 cellular effect Effects 0.000 description 1
- 239000007795 chemical reaction product Substances 0.000 description 1
- 235000012000 cholesterol Nutrition 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 230000002596 correlated effect Effects 0.000 description 1
- 230000002559 cytogenic effect Effects 0.000 description 1
- 206010061428 decreased appetite Diseases 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 230000002950 deficient Effects 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- 230000008021 deposition Effects 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 238000002224 dissection Methods 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 210000002257 embryonic structure Anatomy 0.000 description 1
- 230000001804 emulsifying effect Effects 0.000 description 1
- 230000037149 energy metabolism Effects 0.000 description 1
- 238000004146 energy storage Methods 0.000 description 1
- 230000002922 epistatic effect Effects 0.000 description 1
- 102000015694 estrogen receptors Human genes 0.000 description 1
- 108010038795 estrogen receptors Proteins 0.000 description 1
- 238000001400 expression cloning Methods 0.000 description 1
- 239000007850 fluorescent dye Substances 0.000 description 1
- 101150055782 gH gene Proteins 0.000 description 1
- 238000001502 gel electrophoresis Methods 0.000 description 1
- 102000054767 gene variant Human genes 0.000 description 1
- 238000012252 genetic analysis Methods 0.000 description 1
- 102000054766 genetic haplotypes Human genes 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 239000000122 growth hormone Substances 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 231100000206 health hazard Toxicity 0.000 description 1
- 230000009097 homeostatic mechanism Effects 0.000 description 1
- 230000013632 homeostatic process Effects 0.000 description 1
- 210000004754 hybrid cell Anatomy 0.000 description 1
- 210000003016 hypothalamus Anatomy 0.000 description 1
- 230000002998 immunogenetic effect Effects 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 229940125396 insulin Drugs 0.000 description 1
- 230000003834 intracellular effect Effects 0.000 description 1
- 238000002955 isolation Methods 0.000 description 1
- 235000020997 lean meat Nutrition 0.000 description 1
- 239000003446 ligand Substances 0.000 description 1
- 238000007834 ligase chain reaction Methods 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 108020004999 messenger RNA Proteins 0.000 description 1
- 239000002480 mineral oil Substances 0.000 description 1
- 235000010446 mineral oil Nutrition 0.000 description 1
- 239000013642 negative control Substances 0.000 description 1
- 230000007372 neural signaling Effects 0.000 description 1
- 230000000955 neuroendocrine Effects 0.000 description 1
- BPGXUIVWLQTVLZ-OFGSCBOVSA-N neuropeptide y(npy) Chemical compound C([C@@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(O)=O)NC(=O)[C@H](CC=1N=CNC=1)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](C)NC(=O)[C@H]1N(CCC1)C(=O)[C@H](C)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)CNC(=O)[C@H]1N(CCC1)C(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H]1N(CCC1)C(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H]1N(CCC1)C(=O)[C@@H](N)CC=1C=CC(O)=CC=1)C1=CC=C(O)C=C1 BPGXUIVWLQTVLZ-OFGSCBOVSA-N 0.000 description 1
- 230000037434 nonsense mutation Effects 0.000 description 1
- URPYMXQQVHTUDU-OFGSCBOVSA-N nucleopeptide y Chemical compound C([C@@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(N)=O)NC(=O)[C@H](CC=1NC=NC=1)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](C)NC(=O)[C@H]1N(CCC1)C(=O)[C@H](C)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)CNC(=O)[C@H]1N(CCC1)C(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H]1N(CCC1)C(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H]1N(CCC1)C(=O)[C@@H](N)CC=1C=CC(O)=CC=1)C1=CC=C(O)C=C1 URPYMXQQVHTUDU-OFGSCBOVSA-N 0.000 description 1
- 239000002777 nucleoside Substances 0.000 description 1
- 150000003833 nucleoside derivatives Chemical class 0.000 description 1
- 210000004940 nucleus Anatomy 0.000 description 1
- 238000010422 painting Methods 0.000 description 1
- 101150006864 ped gene Proteins 0.000 description 1
- 230000002093 peripheral effect Effects 0.000 description 1
- 235000021317 phosphate Nutrition 0.000 description 1
- 150000003013 phosphoric acid derivatives Chemical class 0.000 description 1
- 230000019612 pigmentation Effects 0.000 description 1
- 235000015277 pork Nutrition 0.000 description 1
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 1
- 229940097325 prolactin Drugs 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 238000010791 quenching Methods 0.000 description 1
- 239000011541 reaction mixture Substances 0.000 description 1
- 230000009892 regulation of energy homeostasis Effects 0.000 description 1
- 230000001850 reproductive effect Effects 0.000 description 1
- 238000012552 review Methods 0.000 description 1
- 102200067231 rs1805009 Human genes 0.000 description 1
- 238000005070 sampling Methods 0.000 description 1
- 235000003441 saturated fatty acids Nutrition 0.000 description 1
- 150000004671 saturated fatty acids Chemical class 0.000 description 1
- 238000012216 screening Methods 0.000 description 1
- 238000010187 selection method Methods 0.000 description 1
- 210000000582 semen Anatomy 0.000 description 1
- 230000008054 signal transmission Effects 0.000 description 1
- 238000007619 statistical method Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 230000020382 suppression by virus of host antigen processing and presentation of peptide antigen via MHC class I Effects 0.000 description 1
- 238000013519 translation Methods 0.000 description 1
- 239000001226 triphosphate Substances 0.000 description 1
- 235000011178 triphosphate Nutrition 0.000 description 1
- 125000002264 triphosphate group Chemical class [H]OP(=O)(O[H])OP(=O)(O[H])OP(=O)(O[H])O* 0.000 description 1
- 238000012800 visualization Methods 0.000 description 1
- 238000011680 zucker rat Methods 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/124—Animal traits, i.e. production traits, including athletic performance or the like
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/156—Polymorphic or mutational markers
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/172—Haplotypes
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Organic Chemistry (AREA)
- Analytical Chemistry (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Microbiology (AREA)
- Immunology (AREA)
- Molecular Biology (AREA)
- Biotechnology (AREA)
- Biophysics (AREA)
- Physics & Mathematics (AREA)
- Biochemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Description
WO 00/06777 PCT/US99/16862 TITLE: MELANOCORTIN-4 RECEPTOR GENE AND USE AS A GENETIC MARKER FOR FAT CONTENT, WEIGHT GAIN, AND/OR FEED CONSUMPTION OF ANIMALS 5 CROSS-REFERENCE TO RELATED APPLICATIONS This application claims the benefit of U.S. Provisional Application Serial No. 60/094,287 filed July 27, 1998 and U.S. Provisional Application Serial No. 60/116,186, filed January 15, 1999, the disclosures of which are hereby incorporated by reference. 10 GRANT REFERENCE CLAUSE This invention was supported at least in part by grants from the United States Department of Agriculture through the Iowa Agriculture and Home Economics Experiment Station (IaHees) and Project Number IOW03148 (Hatch Funds). The United States government may have certain rights in this invention. 15 FIELD OF THE INVENTION The present invention relates to a method of genetically evaluating animals by assaying for the presence of at least one genetic marker which is indicative of one or more of the traits of fat content, growth rate, and feed consumption. In particular, the method 20 analyzes for variation in the melanocortin-4 receptor (MC4R) gene which is indicative of these traits. Even more particularly, the method analyzes for a polymorphism in the MC4R gene. BACKGROUND OF THE INVENTION 25 There is an increasing consumer demand for meat products having low fat content. This demand is fueled by accumulating evidence in the scientific literature that a high consumption of animal fat, especially fat with a high proportion of saturated fatty acids, represents a significant health hazard, including risk for cardiovascular disease. Other health concerns associated with high fat meats include 30 their high content of cholesterol and the addition of relatively high amounts of salt which are added to improve the binding characteristics since salt aids in extracting the native 1 WO 00/06777 PCT/US99/16862 water binding component myosin from the meat. Furthermore, an increasing number of consumers find meat products containing chemical additives such as phosphates, emulsifying additives, and anti-oxidants less acceptable. Faced with consumers who seek a healthier meat product, meat producers are 5 continually pressed to offer cheaper and healthier products. Cheaper products, of course, come from lowering costs of production. Producers are always interested in improving the growth rate and feed conversion of their animals. Lower production costs come from the shorter time to market and lower costs of feeding an animal. This can increase the profit margin in the livestock industry and/or result in lower 10 prices to the consumer. By being able to select for animals which have the aforementioned traits, producers can raise animals with these desirable characteristics. Selection for desirable traits has traditionally been done using breeding techniques. Genetic differences exist among individual meat producing animals as well as 15 among breeds which can be exploited by breeding techniques to achieve animals with these desirable characteristics. For example, Chinese breeds are known for reaching puberty at an early age and for their large litter size, while American breeds are known for their greater growth rates and leanness. Thus, it would be desirable to combine the best characteristics of both types of these breeds, thereby improving pork production. 20 Often, however, heritability for desired traits is low, for example, heritability for litter size is around 10%-15%. Standard breeding methods which select individuals based upon phenotypic variations do not take fully into account genetic variability or complex gene interactions which exist. Therefore, there is a need for an approach that deals with selection for leanness, growth rate, and feed consumption at the cellular or DNA level. 25 This method will provide a method for genetically evaluating animals to enable breeders to more accurately select those animals which not only phenotypically express desirable traits but those which express favorable underlying genetic criteria. This has largely been accomplished to date by marker assisted selection. Restriction fragment length polymorphism (RFLP) analysis has been used by 30 several groups to study pig DNA. Jung et al., Theor. Appl. Genet., 77:271-274 (1989), incorporated herein by reference, discloses the use of RFLP techniques to show genetic 2 WO 00/06777 PCT/US99/16862 variability between two pig breeds. Polymorphism was demonstrated for swine leukocyte antigen (SLA) Class I genes in these breeds. Hoganson et al., Abstract for Annual Meeting of Midwestern Section of the American Society of Animal Science, March 26-28, 1990, incorporated herein by reference, reports on the polymorphism of swine major 5 histocompatibility complex (MHC) genes for Chinese pigs, also demonstrated by RFLP analysis. Jung et al., Animal Genetics, 26:79-91 (1989), incorporated herein by reference, reports on RFLP analysis of SLA Class I genes in certain boars. The authors state that the results suggest that there may be an association between swine SLA/MHC Class I genes and production and performance traits. They further state that the use of SLA Class I 10 restriction fragments, as genetic markers, may have potential in the future for improving pig growth performance. The ability to follow a specific favorable genetic allele involves a novel and lengthy process of the identification of a DNA molecular marker for a major effect gene. The marker may be linked to a single gene with a major effect or linked to a number of genes 15 with additive effects. DNA markers have several advantages; segregation is easy to measure and is unambiguous, and DNA markers are co-dominant, i.e., heterozygous and homozygous animals can be distinctively identified. Once a marker system is established selection decisions could be made very easily, since DNA markers can be assayed any time after a tissue or blood sample can be collected from the individual infant animal. 20 The use of genetic differences in receptor genes has become a valuable marker system for selection. For example, United States Patents 5,550,024 and 5,374,526 issued to Rothschild et al. disclose a polymorphism in the pig estrogen receptor gene which is associated with larger litter size, the disclosure of which is incorporated herein by reference. United States application serial number 08/812,208 discloses polymorphic 25 markers in the pig prolactin receptor gene which are associated with larger litter size and overall reproductive efficiency. It can be seen from the foregoing that a need exists for a method for selecting animals with the improved metabolic traits regarding fat content, growth rate, and feed consumption. 30 3 WO 00/06777 PCT/US99/16862 SUMMARY OF THE INVENTION An object of the present invention is to provide a genetic marker based on or within the MC4R gene which is indicative of fat content, growth rate, and/or feed consumption. Another object of the invention is to provide an assay for determining the presence 5 of this genetic marker. A further object of the invention is to provide a method of evaluating animals that increases accuracy of selection and breeding methods for the desired traits. Yet another object of the invention is to provide a PCR amplification test which will greatly expedite the determination of presence of the marker. 10 An additional object of the invention is to provide a kit for evaluating a sample of animal DNA for the identified genetic marker. These and other objects, features, and advantages will become apparent after review of the following description and claims of the invention which follow. This invention relates to the discovery of a polymorphism within the melanocortin 15 4 receptor (MC4R) gene which is associated with fat content, growth rate, and feed conversion traits in animals. According to the invention, the association of the MC4R polymorphism with the trait(s) enables genetic markers to be identified for specific breeds or genetic lines. The TaqI restriction pattern which identifies the polymorphism is used to assay for the presence or absence of markers associated with the desirable metabolic traits. 20 The breed-dependent marker genotype (i.e., a marker in some breeds and a nonmarker in others) consists of a polymorphism within MC4R, a guanine to adenine transition at position 678 of the PCR product (a missense mutation of aspartic acid codon (GAU) into asparagine codon (AAU) at position 298 amino acid of the MC4R protein). The invention includes assays for detection of the marker as well as the sequence characterization of the 25 polymorphism and includes novel sequences in the MC4R gene which may be used to design amplification primers for such an assay. Additionally, the invention includes a method for using the assay in breeding programs for animal selection and a kit for performing the assay. Definitions 30 As used herein, "low fat content" or "leanness" means a biologically significant decrease in body fat relative to the mean of a given population. 4 WO 00/06777 PCT/US99/16862 BRIEF DESCRIPTION OF THE DRAWINGS Figure 1 is the sequence listing for MC4R in pigs (SEQ ID NO: 1). "X" represents the site of the polymorphism. 5 Figure 2 represents a comparison of the DNA sequence between the human (SEQ ID NO:2) and the porcine (SEQ ID NO:3) MC4R gene. Figure 3 represents a comparison of the amino acid sequence between the human (SEQ ID NO:4) and the porcine (SEQ ID NO:5) MC4R gene. Figures 4a, 4b, and 4c are linkage reports for MC4R from CRI-MAP. 10 Figure 5 depicts partial nucleotide and amino acid sequences (SEQ ID NO: 12) of the porcine MC4R gene. The amino acid translation shows an amino acid substitution at codon 298. Figure 6 is an electrophoresis gel of TaqI digestion of the PCR product. Molecular marker (M) and MC4R genotypes are indicated at the top of each lane. 15 Figure 7 depicts multiple-alignments of the putative seventh transmembrane domain of porcine MC4R with other MCRs and GPCRs. The "*" represents the predicted sequence positions for porcine MC4R. The other amino acid sequences were obtained from the GenBank database (accession numbers P32245, P70596, P41983, P5645 1, P34974, P41968, P33033, Q01718, Q01726, Q28031, AFO 1466, P21554, P18089, 20 P30680, P4721 1). The missense variant in porcine MC4R substituted amino acid N for D in the position marked with an arrow. The Asp (D) residue is highly conserved among MCRs, and the Asn (N) residue is well conserved in most other GPCRs. DETAILED DESCRIPTION OF THE PREFERRED EMBODIMENT 25 Obesity is a disease affecting energy balance. The control of energy metabolism is simple: store excessive energy as fat and manage the energy to avoid superfluous energy storage, i.e., obesity. Although several genes and signaling systems have been implicated in obesity, there has been little known about the interconnection of energy homeostatic mechanism and genetic polymorphism. The melanocortin-4 receptor (MC4R) has been 30 shown to be an important mediator of long term weight homeostasis. MC4R antagonists can increase food intake and body weight during chronic administration. Skuladottir, G.V., 5 WO 00/06777 PCT/US99/16862 et al., "Long term orexigenic effect of a novel melanocortin 4 receptor selective antagonist", British J. of Pharm., 126(1):27-34 (1999). Lu et al. (1994) suggested that the melanocortin receptors are involved in controlling food intake and energy balance through studying its antagonism to the agouti 5 obesity syndrome. Huszar et al. (1997) found that inactivation of the melanocortin-4 receptor gene (MC4R) resulted in a maturity onset obesity syndrome in mice and demonstrated a major role of MC4R protein in the regulation of energy balance related to the agouti obesity syndrome. In addition, the MC4R protein mediates the effects of leptin, one of the important signaling molecules in energy homeostasis (Seeley et al. 1997). 10 According to the present invention, a variant or polymorphism in the MC4R gene has been located, and this genetic variability is associated with phenotypic differences in the metabolic traits of fat content, growth rate, and/or feed consumption. In one embodiment of the invention, an assay is provided for detection of presence of a desirable genotype. The assay involves amplifying the genomic DNA purified from 15 blood, tissue, semen, or other convenient source of genetic material by the use of primers and standard techniques, such as the polymerase chain reaction (PCR), then digesting the DNA with a restriction enzyme (e.g., Taq 1) so as to yield gene fragments of varying lengths, and separating at least some of the fragments from others (e.g., using electrophoresis). 20 The fragments may also be detected by hybridizing with a nucleotide probe (e.g., radio-labeled cDNA probes) that contains all or at least a portion of the MC4R gene cDNA sequence to the separated fragments and comparing the results of the hybridization with assay results for a gene sequence known to have the marker or a sequence known to not have the marker. Selection and use of probes for detection of MC4R sequences based on 25 the known and disclosed MC4R sequences is generally known to those skilled in the art. The probe may be any sequence which will hybridize to the separated digestion products and allow for detection. Another embodiment of the invention provides a kit for assaying the presence in a MC4R gene sequence of a genetic marker. The marker being indicative of inheritable traits 30 of fat content, growth rate, and/or feed consumption. The kit in a preferred embodiment also includes novel PCR primers comprising 4-30 contiguous bases on either side of the 6 WO 00/06777 PCTIUS99/16862 polymorphism to provide an amplification system allowing for detection of the Taq I polymorphism by PCR and Taq I digestion of PCR products. The preferred primers are SEQ ID NO:8 and SEQ ID NO:9. A further embodiment comprises a breeding method whereby an assay of the above 5 type is conducted on a plurality of gene sequences from different animals or animal embryos to be selected from and based on the results, certain animals are either selected or dropped out of the breeding program. According to the invention, the polymorphism in the MC4R gene, identifiable by the Taq I restriction pattern, is disclosed. As is known in the art, restriction patterns are not 10 exact determinants of the size of fragments and are only approximate. The polymorphism is identifiable by three bands from a Taq I digestion of the PCR product, 466, 225, and 76 base pairs (bp) for one homozygous genotype (allele 1); two bands, 542 and 225 bp for another homozygous genotype (allele 2); and four bands for the heterozygous genotype (542, 466, 225, and 76 bp). The marker for leanness and lower feed intake is identifiable 15 by the 466/225/76 bands, except for the Chinese pigs, where the Chinese pigs' marker for leanness is the 542/225 bands. The marker for faster rate of gain is identifiable by the 542/225 bands. In addition, the polymorphism associated with the pattern has been identified at the nucleotide level. The polymorphic Taq I site was sequenced along with the general 20 surrounding area. See SEQ ID NO: 1. The sequences surrounding the polymorphism have facilitated the development of a PCR test in which a primer of about 4-30 contiguous bases taken from the sequence immediately adjacent to the polymorphism is used in connection with a polymerase chain reaction to greatly amplify the region before treatment with the Taq I restriction enzyme. The primers need not be the exact complement; substantially 25 equivalent sequences are acceptable. From sequence data, it was observed that in allele 2 the guanine is substituted with an adenine at position 678 of the PCR product or at position 298 amino acid of the MC4R protein changing the aspartic acid codon (GAU) into an asparagine codon (AAU). The PCR test for the polymorphism used a forward primer of 5'-TGG CAA TAG CCA AGA 30 ACA AG-3' (SEQ. ID NO: 6) and a reverse primer of 5'-CAG GGG ATA GCA ACA GAT GA-3' (SEQ. ID NO: 7). Pig specific primers used were a forward primer of 5'-TTA 7 WO 00/06777 PCT/US99/16862 AGT GGA GGA AGA AGG-3' (SEQ. ID NO: 8) and a reverse primer of 5'-CAT TAT GAC AGT TAA GCG G-3' (SEQ ID NO:9). The resulting amplified product of about 75O bp, when digested with Taq I, results in allelic fragments of 466, 225, and 76 bp (allele 1) or 542 and 225 bp (allele 2). 5 The marker may be identified by any method known to one of ordinary skill in the art which identifies the presence or absence of the marker, including for example, single strand conformation polymorphism analysis (SSCP), RFLP analysis, heteroduplex analysis, denaturing gradient gel electrophoresis, and temperature gradient electrophoresis, ligase chain reaction or even direct sequencing of the MC4R gene and examination for the io Taq I RFLP recognition pattern. One or more additional restriction enzymes and/or probes and/or primers can be used. Additional enzymes, constructed probes, and primers can be determined by routine experimentation by those of ordinary skill in the art. Other possible techniques include non-gel systems such as TaqMan TM (Perkin 15 Elmer). In this system, oligonucleotide PCR primers are designed that flank the mutation in question and allow PCR amplification of the region. A third oligonucleotide probe is then designed to hybridize to the region containing the base subject to change between different alleles of the gene. This probe is labeled with fluorescent dyes at both the 5' and 3' ends. These dyes are chosen such that while in this proximity to each other the 20 fluorescence of one of them is quenched by the other and cannot be detected. Extension by Taq DNA polymerase from the PCR primer positioned 5' on the template relative to the probe leads to the cleavage of the dye attached to the 5' end of the annealed probe through the 5' nuclease activity of the Taq DNA polymerase. This removes the quenching effect allowing detection of the fluorescence from the dye at the 3' end of the probe. The 25 discrimination between different DNA sequences arises through the fact that if the hybridization of the probe to the template molecule is not complete, i.e., there is a mismatch of some form, the cleavage of the dye does not take place. Thus, only if the nucleotide sequence of the oligonucleotide probe is completely complementary to the template molecule to which it is bound will quenching be removed. A reaction mix can 30 contain two different probe sequences each designed against different alleles that might be present, thus, allowing the detection of both alleles in on reaction. 8 WO 00/06777 PCT/US99/16862 Though the use of RFLPs is one method of detecting the polymorphism, other methods known to one of ordinary skill in the art may be used. Such methods include ones that analyze the polymorphic gene product and detect polymorphisms by detecting the resulting differences in the gene product. 5 Though the preferred method of separating restriction fragments is gel electrophoresis, other alternative methods known to one skilled in the art may be used to separate and determine the size of the restriction fragments. It is possible to indirectly select for the polymorphism with alternative DNA markers. It is possible to establish a linkage between specific alleles of alternative DNA 10 markers and alleles of DNA markers known to be associated with the MC4R gene which have previously been shown to be associated with a particular trait. Examples of markers on the published PiGMaP chromosome map which are linked to the MC4R gene include S0331, BHT0433, and S0313. The reagents suitable for applying the methods of the present invention may be 15 packaged into convenient kits. The kits provide the necessary materials, packaged into suitable containers. At a minimum, the kit contains a reagent that identifies the polymorphism in the MC4R gene that is associated with the traits of interest, fat content, growth rate, and feed consumption. Preferably, the reagent that identifies the polymorphism is a PCR set (a set of primers, DNA polymerase, and four nucleoside 20 triphosphates) that hybridize with the MC4R gene or a fragment thereof. Preferably, the PCR set and restriction enzyme that cleaves the MC4R gene in at least one place are included in the kit. Preferably, the kit further comprises additional means, such as reagents, for detecting or measuring the detectable entity or providing a control. Other reagents used for hybridization, prehybridization, DNA extraction, visualization, and 25 similar purposes may also be included, if desired. The genetic markers, methods, and kits of the invention are useful in a breeding program to improve fat content, growth rate, and feed consumption characteristics in a breed, line, or population of animals. Continuous selection and breeding of animals that are at least heterozygous and preferably homozygous for the desired polymorphism 30 associated with the particular trait would lead to a breed, line, or population having those desired traits. Thus, the marker is a selection tool. 9 WO 00/06777 PCT/US99/16862 The following examples are offered to illustrate, but not limit the invention. EXAMPLE 1 5 Melanocortin 4 Receptor PCR-RFLP Test - TaqI polymorphism and Genetic Linkage Mapping of MC4R Gene Primers: Primers were designed from homologous regions of human and rat MC4R 10 sequences (Genbank Accession No. s77415 and u67863, respectively). These primers were used to amplify a 750-bp sequence of the porcine MC4R gene. MC4R1: 5' TGG CAA TAG CCA AGA ACA AG 3' (SEQ ID NO:6) MC4R4: 5' CAG GGG ATA GCA ACA GAT GA 3' (SEQ ID NO:7) 15 PCR Conditions: Mix 1: 1OX Promega Buffer 1.0 pL 25 mM MgCl 2 0.6 p.L dNTPs mix (2.5mM each) 0.5 ptL 25 pmol/pL MC4R1 0.1 ptL 25 pmol/pL MC4R4 0.1 ptL dd sterile H 2 0 7.5 ptL Taq Polymerase (5 U/pL) 0.07 pL Genomic DNA (12.5 ng/pL) 1.0 ptL Ten tL of Mix 1 and DNA were combined in reaction tube, then overlaid with mineral oil. The following PCR program was run: 94*C for 2 min.; 35 cycles of 94*C for 20 30 sec.; 58*C 1 min., and 72*C 1 min. 30 sec.; followed by a final extension at 72 0 C for 15 mm. 10 WO 00/06777 PCTIUS99/16862 Five pl of the PCR reaction product was checked on a standard 1% agarose gel to confirm amplification success and clean negative control. Product size is approximately, 750 base pairs. Digestion was performed by the following procedure. TaqI Digestion Reaction 10 pL reaction PCR product 5.0 pL lOX TaqI NE Buffer 1.0 pL BSA (1Omg/ml) 0.1 pL TaqI enzyme (20 U/pL) 0.5 pL dd sterile H 2 0 3.4 tL 5 A cocktail of the buffer, enzyme, BSA, and water was made. Five pLL was added to each reaction tube containing the DNA. The mixture was then incubated at 65*C for at least 4 hours to overnight. Loading dye was mixed with the digestion reaction and the total volume was loaded on a 3% agarose gel. The major bands for allele 1 are about 466, 225, 10 and 76 bp. The allele 2 genotype bands are 542 and 225 bp. The heterozygote genotype has both allele 1 and allele 2. Results The amplified PCR product is about 750 bp. The sequence of the PCR product 15 confirmed that the PCR product is MC4R gene with 97.6%, and 92.2% identities at the amino acid and DNA level, respectively, to corresponding human sequences. (see Figs. 2 and 3). The TaqI digestion of the PCR product produced allelic fragments of 466, 225, and 76 bp (allele 1), or 542 and 225 bp (allele 2). The heterozygote genotype has both types of 20 alleles. Mendelian inheritance was observed in three three-generation international reference families, which were used to map this gene by linkage analysis. The polymorphism between allele 1 and allele 2 resulting from a G -* A transition at position 678 of the PCR product revealed a missense mutation of Aspartic acid codon (GAU) into Asparagine codon (AAU) at position 298 amino acid of MC4R protein. (See 25 Figure 1, SEQ ID NO:1). 11 WO 00/06777 PCT/US99/16862 Allele frequencies were determined by genotyping of DNA samples from a small number of animals from different breeds (Table 1). Allele 1 was observed with a frequency of 1 in Meishan, but was not observed or observed at very low frequency in Hampshire and Yorkshire. The frequencies of allele 1 in Landrace and Chester White were 5 0.5, respectively. Figures 2 and 3 illustrate the differences between the DNA and amino acid sequences of the human and porcine MC4R gene (SEQ ID NOS:2-5). TABLE 1 10 The Frequency of Allele 1 in Different Pig Breeds Breed # Animals Freq. Allele 1 Meishan 8 1 Large White 8 0.56 Yorkshire 6 0.08 Hampshire 5 0 Landrace 4 0.5 Chester White 4 0.5 Minzu 2 1 Wild Boar 2 1 Linkage Analyses Two-point and multi-point linkage analyses were performed on the genotypes of 15 international reference families. See Figs. 4a-4c. The data were analyzed by using the CRI-MAP program. MC4R was significantly linked to several markers on porcine chromosome (SSC) 1. The most closely linked markers (recombination fraction and LOD score in parentheses) are S0331 (0.02, 21.97), BHT0433 (0.02, 21.32), and S0313 (0.00, 17.76) by two-point linkage analysis. A multi-point linkage analysis produced the best 20 map order of markers and MC4R (with distance in Kosambi cM): KGF-5.8-CAPN3-2.5 MEF2A-6. 1 -MC4R-5.6-SO313. 12 WO 00/06777 PCT/US99/16862 Somatic cell hybrid panel of pig and rodent was used to assign MC4R to a cytogenetic region. PCR products from pig specific primers were amplified in clones 7, 8 16, 18, and 19. MC4R was localized to SSClq 22-27. 5 EXAMPLE 2 MC4R Receptor PCR-RFLP Test using Pig Specific Primers and Genetic Linkage Mapping of the Porcine MC4R Gene Pig Specific Primer Sequences 10 Forward primer: 5'-TTA AGT GGA GGA AGA AGG-3' (SEQ ID NO:8) Reverse primer: 5'-CAT TAT GAC AGT TAA GCG G-3' (SEQ ID NO:9) Method of Detection The PCR reaction was performed using 15 Porcine genomic DNA 12.5 ng lx PCR buffer MgCl 2 1.5 mM dNTP 0.125 mM Forward primer 0.3 p.M Reverse primer 0.3 p.M Taq DNA polymerase (Promega) 0.35 U in a 10 p.L final volume. The PCR profile included 2 min. at 94*C; 35 cycles of 30 sec. at 94*C, 1 min. at 56*C, 1 min. 30 sec. at 72*C; and 15 min. at 72*C in a Robocycler (Statagene, La Jolla, CA). A 5.0 p.L aliquot of the PCR products was digested in a total 20 volume of 10 p.L with 10 U of TaqI incubated overnight at 65'C. The digestion products were electrophoresed on a 3% agarose gel. 13 WO 00/06777 PCT/US99/16862 Description of Polymorphism The TaqI digestion of the PCR product produced fragments of 466, 225, and 76 bU in allele 1 and 542 and 225 bp in allele 2. The heterozygous genotype has fragments of both allele 1 and allele 2. 5 Pattern of Inheritance Autosomal segregation of Mendelian inheritance was observed in three three generation European PiGMaP families (Archibald et al., 1995). 10 Allele Frequencies Allele frequencies were determined by genotyping the grandparental animals of the European PiGMaP families and unrelated animals from ISU reference families. Allele 1 was observed with the following frequencies. 15 TABLE 2 The Frequency of Allele 1 in Different Pig Breeds Breed # Animals Freq. Allele 1 Meishan 8 1 Large White 8 0.56 Yorkshire 10 0.15 Hampshire 12 0 Landrace 8 0.56 Chester White 8 0.56 Minzu 2 1 Wild Boar 2 1 Chromosomal Location 20 Two-point and multi-point linkage analysis were performed on the genotypes of three PiGMaP families using the CRI-MAP program (Green et al. 1990). MC4R was 14 WO 00/06777 PCTIUS99/16862 significantly linked to several markers on porcine chromosome 1 (SSC 1). The most closely linked markers (recombination fraction and LOD score in parentheses) are S0331 (0.02, 21.97), BHT0433 (0.02, 21.32), and S0313 (0.00, 17.76) according to two-point linkage analysis. The best map order of MC4R with respect to other linked markers 5 produced by multi-point linkage analysis is as follows (with distance in Kosambi cM): KGF-5.8-CAPN3-2.5-MEF2A-6. 1 -MC4R-5.6-SO313. Comments The Melanocortin-4 Receptor is a G protein-coupled, seven-transmembrane 10 receptor expressed in the brain. Huszar et al. (1997) found that inactivation of MC4R gene resulted in a maturity onset obesity syndrome in mice and demonstrated a major role of MC4R protein in the regulation of energy balance. The MC4R gene has been mapped to human chromosome 18q21.3 (Gantz et al., 1993). The localization of MC4R gene to SSC 1 is consistent with previous chromosome painting data indicating synteny between this 15 chromosome and HSA 18 and 15 (Goureau et al., 1996). However, the gene order of several genes previously mapped from HSA 18 and 15 to SSC 1, including CAPN3, KGF, and MEF2A, is not conserved with MC4R. Therefore, mapping of MC4R to SSC 1 may identify an evolutionary breakpoint between HSA 18 and 15 in relation to SSC 1. 20 EXAMPLE 3 Association of Marker with Enhanced Metabolic Characteristics In a preliminary study to determine which allele is associated with which trait and in which breeds, the genotypes of several lines of animals were correlated with days to 110 25 kg, backfat measurements, daily gains, and average daily feed intake. The pigs used in the study were from lines from Pig Improvement Company (PIC). Data was accumulated using the PCR test described supra for the 1 and 2 allele of the MC4R gene. The collected data is summarized in Tables 3-8 below. According to the results, allele 1 is the significantly leaner allele (see P2 backfat 30 measurements) in all lines except in Chinese pigs where it is the fat allele. Allele 2 is 15 WO 00/06777 PCT/US99/16862 associated with significantly faster rate of gain (test daily gain) in the tested commercial lines. Overall allele 1 is associated with lower feed intake. TABLE 3 5 Number of observations MC4R L02 L03 L19 L65 Overall L95 genotype 11 88 30 32 150 20 12 57 54 56 74 241 67 22 12 31 254 33 330 37 Total 721 MC4R genotype: 11 = homozygous allele 1 12 = heterozygous 10 22 = homozygous allele 2 TABLE 4 Number of observations (males/females) MC4R L02 L03 L19 L65 Overall L95 genotype 11 9/79 12/18 15/17 36/114 0/20 12 9/48 37/17 12/44 44/30 102/139 0/67 22 3/9 28/3 89/165 21/12 141/189 0/37 15 16 WO 00/06777 PCT/US99/16862 TABLE 5 Days to 110kg MC4R L02 L03 L19 L65 Overall L95 genotype 11 169.7 172.4 169.6 168.5 219.1 12 170.2 171.5 165.0 171.2 168.7 212.2 22 165.3 173.4 162.9 170.3 167.1 211.4 P<.23 P<.75 P<.15 P<.76 P<.31 P<.27 5 TABLE6 P2 backfat (mm) MC4R L02 L03 L19 L65 Overall L95 Genotype 11 10.8 11.9 9.7 11.1 22.8 12 11.3 12.5 12.2 10.5 11.8 21.5 22 12.1 12.7 12.6 10.7 12.1 20.3 P<.10 P<.43 P<.34 P<.17 P<.006 P<.17 TABLE 7 10 Test daily gain (gm/d) MC4R L02 L03 L19 L65 Overall L95 genotype 11 882.2 811.0 881.8 871.9 688.8 12 891.2 820.5 875.6 873.0 876.3 676.2 22 969.1 819.5 906.7 906.2 906.9 692.5 P<.01 P<.96 P<.05 P<.24 P<.006 P<.66 17 WO 00/06777 PCTIUS99/16862 TABLE 8 Average daily feed intake (kg/d), boars only, except L95 which was gilts only MC4R L02 L03 L19 L65 Overall L95 genotype 11 2.31 1.78 1.75 1.89 2.05 12 2.11 1.90 1.97 1.90 1.96 2.03 22 2.15 1.97 2.00 1.97 2.02 2.08 P<.84 P<.14 P<.56 P<.14 P<.16 P<.36 5 EXAMPLE 4 A Missense Variant of the Porcine Melanocortin-4 Receptor (MC4R) Gene is Associated with Fatness, Growth, and Feed Intake Traits To determine if there was an association of this MC4R polymorphism with 10 phenotypic variation the mutation was tested in a large number of individual animals from several different pig lines. Analyses of growth and performance test records showed significant associations of MC4R genotypes with backfat, growth rate and feed intake in a number of lines. It is probable that the variant amino acid residue of the MC4R mutation causes a significant change of the MC4R function. These results support the functional 15 significance of a pig MC4R missense mutation and suggest that comparative genomics based on model species may be equally important for application to farm animals as they are for human medicine. Identification of mutations in the leptin and the leptin receptor has provided some information on genetic components involved in the regulation of energy balance (Zhang et 2 0 al. 1994; Tartaglia et al. 1995). Genetic studies using animal models have facilitated the identification of major genetic causes of obesity (Andersson 1996; Pomp 1997; Giridharan 1998). Furthermore, several other genes involved in the neural signaling pathway of energy homeostasis have been identified (Flier and Maratos-Flier 1998; Schwartz et al. 1999). Of particular interest among candidate signaling molecules involved in the 18 WO 00/06777 PCT/US99/16862 regulation of energy homeostasis is the melanocortin-4 receptor (MC4R). The MC4R response to leptin signaling is a link between food intake and body weight (Seeley et al. 0 1997; Marsh et al. 1999). Neuropeptide Y (NPY) signaling in the central nervous system is also mediated by the MC4R protein (Kask et al. 1998). Several mutations in MC4R 5 including frameshift and nonsense mutations are associated with dominantly inherited obesity in humans (Vaisse et al. 1998; Yeo et al. 1998). Some other MC4R missense mutations in humans have also been identified (Gotoda et al. 1997; Hinney et al. 1999) but the functional significance of these mutations has not been characterized. Selection based on growth characteristics has been of great importance to the pig 10 industry because of costs associated with feeding and consumer preference for lean meat. Efficient genetic improvement in these quantitative traits may be augmented through the use of marker assisted selection (MAS) using high density genetic maps (Dekkers and van Arendonk 1998; Rothschild and Plastow 1999). An important tool in this process is comparative mapping using the well-developed human and mouse gene maps, which assist 15 in the identification of corresponding genomic regions or major genes controlling growth and performance traits in the pig. Biological understanding of complex traits in human or model species offers an alternative approach to identify genes responsible for the traits of economic interest in livestock. Several quantitative trait loci (QTL) linkage scans using phenotypically divergent breeds and candidate gene analyses have been successfully 20 conducted for fatness and growth traits (Yu et al. 1995; Casas-Carrillo et al. 1997; Knorr et al. 1997; Knott et al. 1998; Rohrer et al. 1998; Wang et al. 1998; Paszek et al. 1999), but no individual genes with major effects on growth and performance traits have yet been established for commercial populations. The role of MC4R in feed intake and obesity suggests it may be an important genetic marker for the growth-related traits in the pig. 25 Materials and Methods Animals. Pigs were raised under normal production conditions under the care of PIC employees in nucleus farms in the United States and Europe. Pigs were put on the performance test at approximately 70 days of age and taken off test after 13 weeks. At the 30 end of the trial backfat was measured ultrasonically in real time (B mode) at the 10' rib 2 cm from the centerline. Average daily gain (growth) over the test period was calculated as 19 WO 00/06777 PCT/US99/16862 weight gained divided by days on test. Days to 110 kg market weight was estimated using standard procedures and feed intake was measured using individual electronic measurement equipment. 5 PCR amplification of a pig MC4R gene fragment. Primers were designed from homologous regions of human and rat MC4R sequences (GenBank accession no. s77415 and u67863, respectively). The primers were: forward primer: 5'-TGG CAA TAG CCA AGA ACA AG-3' (SEQ. ID NO:6) and reverse primer: 5'-CAG GGG ATA GCA ACA GAT GA-3' (SEQ. ID NO:7). The PCR reaction was performed using 12.5 ng of porcine 10 genomic DNA, lx PCR buffer, 1.5 mM MgCl 2 , 0.125 mM dNTPs, 0.3 mM of each primer, and 0.35 U Taq DNA polymerase (Promega) in a 10ptL final volume. The conditions for PCR were as follows: 2 min at 94*C; 35 cycles of 30 s at 94*C, 1 min at 56*C, 1 min 30 s at 92*C, and a final 15 min extension at 72*C in a Robocycler (Stratagene, La Jolla, CA). 15 Sequencing and mutation detection. Sequencing of the PCR products from several individual pigs of different breeds was conducted and the sequences were compared to detect any nucleotide change. Sequencing was performed on an ABI sequencer 377 (Applied Biosystems). The porcine MC4R sequence has been submitted to GenBank, and has accession number AF087937. The sequence analysis revealed one nucleotide 20 substitution situated within a TaqI restriction enzyme recognition site (Kim et al. 1999). A set of primers was then designed to generate a smaller MC4R gene fragment, which contained only one informative TaqI restriction site to specify the polymorphic site and to facilitate the PCR-RFLP test. These primers were: forward 5'-TAC CCT GAC CAT CTT GAT TG-3' (SEQ. ID NO:10) and reverse: 5'-ATA GCA ACA GAT GAT CTC TTT G-3' 25 (SEQ. ID NO:11). Statistical analysis. Analysis of variance procedures were used with a mixed model that accounted for the fixed effects of farm, test period, sex of the animal, the MC4R genotype and site (random). All animals in lines of American/European descent (Lines A 30 D) were pooled for the overall analysis and in this analysis line of origin was included. 20 WO 00/06777 PCT/US99/16862 Mean effects were estimated for each genotype and are presented in Tables 9-15. Overall F tests were used to determine level of significance. Results 5 Identification of a missense mutation in the pig MC4R gene. The MC4R gene consists of approximately 1 kb of coding sequence contained within a single exon. About 750 bp of a pig MC4R gene fragment was produced by PCR (Kim et al. 1999). The sequence of the PCR product confirmed that the PCR product is the MC4R gene with 92.2% and 97.6% identities at nucleotide and the amino acid levels, respectively, to the 10 human MC4R sequence. Multiple alignments of the sequences from individual animals of several breeds identified a single nucleotide substitution (G-+A; Fig. 5). The polymorphism revealed a missense mutation that replaces aspartic acid (GAU) with asparagine (AAU) at the position identical to amino acid 298 of human MC4R protein. To confirm this base change, we designed pig-specific primers flanking the polymorphic site 15 and analyzed the polymorphism as a TaqIPCR-RFLP gel (Fig. 6). Figure 6 shows a TaqI digestion of the PCR product analyzed by agarose-gel electrophoresis. Allele 1 produced 156 and 70 bp fragments and allele 2 produced a 226 bp fragment as the PCR-RFLP. The heterozygote has both allele 1 and 2 fragments. Molecular marker (M) and MC4R genotypes are indicated at the top of each lane. 20 The MC4R missense mutation is within a highly conserved region among melanocortin receptors (MCR). The MCR is a subfamily of G-protein coupled receptors (GPCR) containing certain conserved structural elements common to most other GPCRs, but overall amino acid identities between MCR and other GPCRs are low (Tatro 1996). A 25 multiple-alignment of the predicted amino acid sequences of the pig MC4R with MC4R proteins from other species, other MCR proteins, or representative GPCRs showed that the aspartic acid found at position 298 of the seventh transmembrane domain is very highly conserved in the MCR proteins (Fig. 7). It is interesting to note, however, that this position is occupied by asparagine in most other GPCRs. The MCR proteins show 40-80% amino 30 acid identity with each other (Tatro 1996), but the second intracytoplasmic loop and the seventh transmembrane domain are highly conserved among MCR proteins (Gantz et al. 21 WO 00/06777 PCT/US99/16862 1993). Some of the relationships between MCR structure and function have been discovered by the studies of natural and experimental mutations in humans and mice (Robbins et al. 1993; Valverde et al. 1995; Frandberg et al. 1998). These studies indicate that some mutations in highly conserved regions cause structural changes and alter the 5 function of the receptor. The Asp298Asn substitution mutation could have an effect on the function of the receptor. However, this will require further testing but it is known that change of the homologous residue in MC1R (Asp294His) is associated with fair skin and red hair in humans (Valverde et al. 1995). 10 The MC4R missense mutation is associated with obesity-related traits. To investigate the effects of the missense mutation, the relationship of MC4R genotypes was analyzed for the effects on variation in growth rate, backfat, and feed consumed in over 1,800 animals from several commercial pig lines from PIC, an international pig breeding company. The animals were from closed commercial lines of European/American breeds 15 (Lines A-D) together with a line originating from a cross between a European and a Chinese breed (Line E). In lines A-D significant associations of the MC4R genotypes were found for all performance traits. The animals homozygous for allele 1 had on average significantly less backfat (P < .001), lower daily gain (P <.001), and lower feed intake(P < .01) than those of the homozygous 22 genotype animals (Tables 11, 13, & 15). Overall, 20 pigs with the 11 genotype had approximately 9% less backfat than pigs with the 22 genotype (Table 11), whereas pigs with the 22 genotype grow significantly faster (37g/day) than pigs with the 11 genotype (Table 13). These results appear to be a function of appetite because the 22 genotype animals consume considerably more feed (Table 15). The association between the missense variant of the MC4R gene and related performance traits 25 is clearly established in European/American breeds. Although the number of tested animals is much smaller, these results were not seen in the considerably fatter Chinese crossed line (Line E). Interestingly, line E shows a trend for backfat in the opposite direction to that observed in the other lines (Table 11). 22 WO 00/06777 PCT/US99/16862 Discussion The present study clearly demonstrates that the porcine MC4R missense mutatiorois significantly associated with several performance traits in pigs. Allele 1 representing Asp298, the well conserved amino acid within other MCR subtypes and other species 5 MC4R, was associated with less backfat thickness, slower growth rate, and lower feed intake and allele 2 representing Asn298 was associated with fatter, higher feed intake, and faster growing animals. As the highly conserved residues in the melanocortin receptor proteins have important roles for ligand binding or intracellular signal transmission (Tatro 1996), the MC4R variants might exert functionally distinct abilities in the regulation of 10 food intake and body weight. Further testing of this hypothesis will provide important insights into the structural basis of MCR function and a molecular target for the treatment of human obesity. Allele 1 was associated with the fattest animals in Line E, which was derived by crossing a Chinese Large White breed with a line of Meishan origin. This is surprising 15 given that the mutation causes a significant amino acid change in a well-conserved region. The result may be due to sampling. However, if we assume that this result will be significant when more results are added there are several possible explanations. One possibility could be the difference in the background gene effects (epistasis). As growth and fatness are complex polygenic traits, it is certainly possible that the Chinese breed has 20 some distinct allelic interactions derived from several hundred years of isolation and these putative interaction(s) might create variation in polygenic traits within crosses between widely different lines (Frankel and Schork 1996). Several QTL analyses have been conducted for fatness and growth traits using divergent lines (Cases-Carrillo et al. 1997; Knott et al. 1998; Rohrer et al. 1998; Wang et al. 1998; Paszek et al. 1999), but QTL have 25 not been reported near the C4R locus, which maps to chromosome 1 at approximately 80 cm on the linkage map (data not shown). It may mean that the epistatic effects of the MC4R alleles suggested in Line E have made it difficult to observe the MC4R locus in most QTL experiments which have involved crosses between Chinese and European/American lines. It is likely that the effect of some alleles will be variable in the 30 different backgrounds and hard to detect in QTL experiments involving genetically divergent breeds. 23 WO 00/06777 PCTIUS99/16862 The effect of MC4R variant will possibly be explained by further studies on the biological effect caused by this mutation in other pig breeds and lines. However, given the strong relationship of MC4R variants to leanness, growth and feed intake, this mutation could be used immediately for merker assisted selection (Meuwissen and Goddard 1996) to 5 develop lines of pigs to satisfy particular customer requirements. For instance, in sow lines where appetite is normally decreased after farrowing, selection for the MC4R 2 allele could help improve feed intake. Furthermore, in some lines deemed to be too fat, selection for allele 1 could be employed and in lines that were considered too slow growth allele 2 selection could be also employed. Therefore, genotyping for the MC4R mutation in pig 10 breeding lines will improve the selection efficiency of feed related production traits including growth and leanness. The candidate gene approach has also been used for investigating the role of the porcine leptin gene (Jiang and Gibson 1999). However, in the leptin case, although there was evidence for an association between a leptin polymorphism and backfat depth in a cross between a commercial breed and an unimproved line, there 15 was no clear association in the different commercial lines tested (Jiang and Gibson 1999). Therefore, it should not be assumed that since one finds a gene that one can assume a relationship exists. In contrast, with MC4R we have determined that variation in this candidate gene can explain significant variation for backfat, growth rate, and feed intake in commercial lines of pigs. These results with MC4R illustrate the potential value of 20 comparative genetic analyses using candidate genes in livestock genomics. EFFECT OF MC4R GENOTYPE ON SEVERAL PRODUCTION TRAITS IN THE PIG TABLE 9 25 Number of observations (males/females/totals) for Days to 110 kg and backfat MC4 LINE A LINE B LINE C LINE D Total Line E R 11 9/212/221 12/94/106 37/17/54 58/323/381 0/20/20 12 9/150/159 37/96/133 12/158/170 152/30/182 210/434/644 0/67/67 22 3/16/19 28/36/64 89/356/445 155/12/167 275/420/695 0/37/37 24 WO 00/06777 PCTIUS99/16862 TABLE 10 Days to 110kg MC4 LINE A LINE B LINE C LINE D Total Line E R 11 166.3+/-0.8 168.4+/-1.4 170.0+/-2.4 167.9+/-0.9 219.1+/-4.8 12 165.6+/-0.9 166.8+/-1.1 163.9+/-1.0 170.2+/-1.8 166.9+/-0.8 212.2+/-3.4 22 162.3+/-2.3 166.8+/-1.5 161.5+/-0.8 167.0+/-1.9 164.6+/-0.9 211.4+/-4.0 P <.24 P <.47 P <.007 P <.10 P <.001 P <.27 5 TABLE 11 1 0* rib Backfat (mm) MC4 LINE A LINE B LINE C LINE D Total Line E R 11 10.7+/-0.2 12.1+/-0.2 9.8+/-0.5 11.1+/-0.2 22.8+/-1.2 12 11.2+/-0.2 12.5+/-0.2 12.3+/-0.2 10.5+/-0.4 11.6+/-0.2 21.5+/-0.9 22 12.5+/-0.5 12.6+/-0.3 12.7+/-0.2 10.9+/-0.4 12.0+/-0.2 20.3+/-1.0 P <.02 P <.31 P <.06 P <.05 P <.001 P <.17 TABLE 12 Number of observations (males/females/totals for Test daily gain MC4 LINE A LINE B LINE C LINE D Total Line E R 11 9/105/114 12/38/50 37/17/54 58/160/218 0/20/20 12 9/65/74 37/35/72 12/97/109 152/30/182 210/227/437 0/67/67 22 3/13/15 28/15/43 89/225/314 155/12/167 275/265/539 0/37/37 10 25 WO 00/06777 PCT/US99/16862 TABLE 13 Test daily gain (gm/day) MC4 I LINE A LINE B L1NE C LINE D Total Line E R 11 892.6+/-10.4 841.7+/-13.8 882.2+/-18.4 871.9+/-10.2 688.8+/-24.5 12 913.3+/-11.6 868.4+/-12.1 882.2+/-12.9 883.7+/-14.3 885.1+/-8.9 676.2+/-17.6 22 982.8+/-22.8 862.4+/-15.1 913.4+/-10.5 904.6+/-15.1 908.8+/-9.3 692.5+/-20.4 P <.001 P <.28 P <.006 P <.20 P <.001 P <.66 TABLE 14 Number of observations (males/females/total) for average daily feed intake MC4R LINE A LINE B LINE C LINE D Total Line E 11 7/0/7 11/0/11 13/0/13 31/0/31 0/18/18 12 8/0/8 31/0/31 9/0/9 34/0/34 82/0/82 0/63/63 22 3/0/3 25/0/25 74/0/74 16/0/16 118/0/118 0/32/32 TABLE 15 Average daily feed intake (kg/day), boars only except LINE E which was gilts only MC4 LINE A LINE B LINE C LINE D Total Line E R 11 2.31+/-0.2 1.78+/-0.09 1.75+/-0.06 1.94+/-0.07 2.05+/-0.10 12 2.11+/-0.3 1.90+/-0.07 1.97+/-0.10 1.90+/-0.07 2.03+/-0.06 2.03+/-0.07 22 2.15+/-0.4 1.97+/-0.06 2.00+/-0.07 1.97+/-0.08 2.11+/-0.06 2.08+/-0.08 P <.84 P <.14 P <.56 P <.14 P <.01 P <.36 Having described the invention with reference to particular compositions, theories of effectiveness, and the like, it will be apparent to those of skill in the art that it is not intended that the invention be limited by such illustrative embodiments or mechanisms, and that modifications can be made without departing from the scope or spirit of the 26 WO 00/06777 PCT/US99/16862 invention, as defined by the appended claims. It is intended that all such obvious modifications and variations be included within the scope of the present invention as defined in the appended claims. The claims are meant to cover the claimed components and steps in any sequence which is effective to meet the objectives there intended, unless 5 the context specifically indicates to the contrary. The following citations are hereby incorporated in their entirety by reference: Andersson LB (1996) "Genes and obesity", Ann Med., 28:5-7. Arden KC (1990). "The Receptors for Prolactin and Growth Hormone are Localized in the 10 same Region of Human Chromosome 5", Cytogenet. Cell Genet. 53:161-165. Barinaga M (1996). "Researchers Nail Down Leptin Receptor", Science 271:913. Bray GA (1978). Physiol. Rev. 59, 719-809. Casas-Carillo E (1997) "Mapping genomic regions associated with growth rate in pigs", J Anim Sci 75:2047-2053. 15 Chajlani V, "Molecular Cloning of a Novel Human Melanocortin Receptor", Biochem. Biophys. Res. Commun., 195, 866-873. Chen H (1995). "Evidence that the diabetes gene encodes the leptin receptor: Identification of a mutation in the leptin receptor gene in db/db mice", Cell 84, 491-495. Chevalet C (1996). CABIOS. In Press. 20 Chua SC (1996). Science 271, 994-996. Chung WK (1996). Genome Res. 6, 431-438. Cioffi JA (1996). Nature Med. 2, 585-589. Cybulsky MI (1991). "Gene Structure, Chromosomal Location, and Basis for Alternative mRNA Splicing of the Human VCAM1 Gene". Proc. Nat. Acad. Sci. 88:7859 25 7863. Dekkers JCM (1998) "Optimizing selection for quantitative traits with information on an identified locus in outbred population", Genet Res 71:257-275. Flier JS (1998), "Obesity and the hypothalamus: Novel peptides for new pathways", Cell 92:437-440. 30 Frandberg P (1997) "Glutaminem and arginem in human melanocortin 5 receptor determines its low affinity to MSH", Biochem Biophys Res Commun 236:489-492. 27 WO 00/06777 PCT/US99/16862 Frankel WN (1996) "Who's afraid of epistasis?" Nat Genet 14:371-373. Gantz I (1993a) "Molecular Cloning of a Novel Melanocortin Receptor", J. Biol. Chem.. 268, 8246-8250. Gantz (1993) "Molecular Cloning, Expression in Gene Localization of a Fourth 5 Melanocortin Receptor", J. Biol. Chem. 268, 15174-15179. Gantz (1994) "Molecular Cloning Expression and Characterization of a Fifth Melanocortin Receptor", Biochem. Biophys. Res. Comm., 200, 1214-1220. Giridharan NV (1998) "Animal models of obesity and their usefulness in molecular approach to obesity", Indian J Med res 108:225-242. 10 Gotoda T (1997) "Molecular screening of the human melanocortin-4 receptor gene: identification of a missense variant showing no association with obesity, plasma glucose, or insulin" Diabetologia 40:976-979. Goureau A (1996). Genomics. In Press. Griffon N (1994) "Molecular Cloning and Characterization of the Rat Fifth Melanocortin 15 Receptor", Biochem. Biophys. Res. Comm., 200, 1007-1014. Helm J (1994) "Rapid Communication: SacI Restriction Fragment Length Polymorphism with a Porcine Vascular Cell Adhesion Molecule 1 (VCAM1) cDNA Fragment", L Anim. Science 72:2764. Hinney A (1999) "Several mutations in the melanocortin-4 receptor gene including a 20 nonsense and a frameshift mutation associated with dominantly inherited obesity in humans" J Clin Endocrinol Metab 84:1483-1486. Huszar (1997) "Targeted disruption of the Melanocortin-4 Receptor Results in /Obesity in Mice", Cell 88:131-141. Kask A (1998) "Evidence that orexigenic effects of melanocortin 4 receptor antagonist 25 HS014 are mediated by neuropeptide Y" Biochem Biophys Res Commun 248:245 249. Kim KS (1999) "Rapid Communication: Linkage and physical mapping of the porcine Melanocortin-4 Receptor (MC4R gene" J Anim Sci (submitted). Knorr C (1997) "Associations of GH gene variants with performance traits in F2 30 generations of European wild boar, Pietrain and Meishan pigs" Anim Genet 28:124-128. 28 WO 00/06777 PCT/US99/16862 Knott SA (1998) "Multiple marker mapping of quantitative trait loci in a cross between outbred wild boar and large white pigs" Genetics 149:1069-1680. Labbe 0 (1994) "Molecular Cloning of a Mouse Melanocortin-5 Receptor Gene Widely Expressed in Peripheral Tissues", Biochemistry, 33, 4543-4549. 5 Lee GH (1996). Nature 379, 632-635. Lu Dongsi "Agouti Protein is an Antagonist of the Melanocyte-Stimulating Hormone Receptor" Letters to Nature. Marsh DJ (1999) "Response of melanocortin-4 receptor-deficient mice to anorectic and orexigenic peptides" Nat Genet 21:119-122. 10 Messer L, (1 996a) "Mapping and Investigation of Candidate Genes for Litter Size in French Large White Pigs" ISAG Proceedings (submitted). Messer L (1996b) "Linkage Mapping of the Retinoic Acid Receptor Gamma (RARG) Gene to Porcine Chromosome 5". Anim. Genet. (in press). Messer L (1996c) "Linkage mapping of the Retinol Binding Protein 4 (RBP4) Gene to 15 Porcine Chromosome 14". Mammal. Genome (in press). Meuwissen THE (1996) "The use of marker haplotypes in animal breeding schemes" Genet Sel Evol 28:161-176. Montjoy KG (1992) "The Cloning of a Family of Genes that Encode the Melanocortin Receptors", Science 257, 1248-1251. 20 Montjoy KG (1994) "Localization of the Melanocortin-4 Receptor (MC4-R) In Neuroendocrine In Autonomic Control Circuits in the Brain" Mol. Endocrinol. 8, 1298-1308. Paszek A (1996) "Genomic Scan for Quantitative Trait Loci in Swine." Proceed. Midwest. ASAS Meeting, p. 24. 25 Paszek AA (1999) "Interval mapping of growth in divergent swine cross" Mamm Genome 10:117-122. Phillips M (1996) "Leptin Receptor Missense Mutation in the Fatty Zucker Rat", Nature Genetics 13:18-19. Pomp D (1997) "Genetic dissection of obesity in polygenic animal models" Behav Genet 30 27:285-306. 29 WO 00/06777 PCT/US99/16862 Robbins LS (1993) "Pigmentation phenotypes of variant extension locus alleles result from point mutations that alter MSH receptor function" Cell 72:827-834. Robic A (1996). Mamm. Genome 7, 438-445. Rohrer GA (1998) "Identification of quantitative trait loci affecting carcass composition in 5 swine: I. Fat deposition traits" J Anim Sci 76:2247-2254. Rothschild MF (1996). "The Estrogen Receptor Locus is Associated With a Major Gene for Litter Size in Pigs". PNAS 93: 201-205. Rothschild MF(1999) "Advances in pig genomics and industry applications" AgBiotechNet 1:1-8. 10 Schwartz MW (1999) "Model for the regulation of energy balance and adiposity by the central nervous system" Am I Clin Nur 69:584-96. Seeley RJ (1997) "Melanocortin receptors in leptin effects", Nature 390:349. Tartaglia LA (1995) "Identification and Expression Cloning of a Leptin Receptor" Cell 83:1263-1271. 15 Tatro JB (1996) "Receptor biology of the melanocortins, a family of neuroimmunomodulatory peptides", Neuroimmunomodulation 3:259-284. Truett GE (1995). Mamm. Genome 6, 25-30. Vaisse C (1998) "A frameshift mutation in human MC4R is associated with a dominant form of obesity" Nat Genet 20:113-114. 20 Valverde P (1995) "Variants of the melanocyte-stimulating hormone receptor gene are associated with red hair and fair skin in humans" Nat Genet 11:328-330. Wang L (1998) "A direct search for quantitative trait loci on chromosomes 4 and 7 in pigs" J Anim Sci 76:2560-2567. Warner CM (1991). "The Swine Major Histocompatibility Complex (SLA)" in 25 Immunogenetics of the MHC, VCH Publishers, NY, NY, pp. 368-397. Winick JD (1996). Genomics 36, 221-222. Xy Y (1994) "Identification of the Ped Gene at the Molecular Level: The Q9 MHC Class I Transgene Converts the Ped Slow Phenotype to Ped Fast Phenotype" Biol. Reprod. 51:695-699. 30 Yeo GS (1998) "A frameshift mutation in MC4R associated with dominantly inherited human obesity" Nat Genet 20:111-112. 30 WO 00/06777 PCT/US99/16862 Yerle M (1996). Cvtogenet. Cell Genet. 73, 194-202. Youngs CR (1993) "Investigation into the Control of Litter Size in Swine: I. Comparative Studies on in vitro Development of Meishan and Yorkshire Preimplantation Embryos" J. Anim. Sci., 1561-1565. 5 Yu TP (1995) "Association of PITI polymorphisms with growth and carcass traits in pigs" J Anim Sci 73:1282-1288. Zhang Y (1994) "Positional cloning of the mouse obese gene and its human homologue", Nature 372:425-432. Ziang ZH (1999) "Genetic polymorphisms in the leptin gene and their association with 10 fatness in four pig breeds" Mamm Genome 12:191-193. 31
Claims (32)
1. A method of identifying an animal which possesses a genotype indicative of the metabolic traits of fat content, growth rate, and feed consumption, the method comprising: 5 a) obtaining a nucleic acid sample from the animal, and b) identifying a polymorphism in the MC4R gene of the sample.
2. The method of claim 1 wherein the polymorphism is characterized by a nucleotide position 678 of the PCR product of the MC4R gene. 10
3. The method of claim 1 wherein the animal is a pig.
4. The method of claim 2 wherein the polymorphism at the nucleotide position 678 is associated with fat content. 15
5. The method of claim 2 wherein a guanine at the nucleotide position 678 is associated with lower feed intake.
6. The method of claim 2 wherein an adenine at the nucleotide position 678 is 20 associated with a faster rate of gain.
7. The method of claim 1 wherein the step of identifying the polymorphism is a method employing allele specific oligonucleotides. 25
8. The method of claim 1 wherein the step of identifying the polymorphism is selected from the group consisting of restriction fragment length polymorphism (RFLP) analysis, heteroduplex analysis, single strand conformational polymorphism (SSCP) analysis, denaturing gradient gel electrophoresis (DGGE),temperature gradient gel electrophoresis (TGGE), and use of linked genetic markers. 30 32 WO 00/06777 PCT/US99/16862
9. The method of claim 8 wherein the step of identifying the polymorphism comprises RFLP analysis. 0
10. The method of claim 1 further comprising the step of amplifying the MC4R gene 5 sequence.
11. The method of claim 10 further comprising the step of digesting the amplified region with the restriction endonuclease Taq I. 10
12. The amplified gene sequence of claim 10 wherein primers used in the amplification are selected from the group consisting of SEQ. ID NO:6, SEQ. ID NO:7, SEQ. ID NO:8, SEQ. ID NO:9, SEQ. ID NO:10, and SEQ. ID NO:11.
13. A single strand of an oligonucleotide primer useful for detecting nucleotide 678 of 15 the PCR product of a MC4R gene the primer consisting of a nucleotide sequence having about 4-30 contiguous bases from SEQ ID NO: 1.
14. The oligonucleotide of claim 13 wherein the oligonucleotide has the nucleotide sequence represented by SEQ ID NO:6. 20
15. The oligonucleotide of claim 13 wherein the oligonucleotide has the nucleotide sequence represented by SEQ ID NO:7.
16. The oligonucleotide of claim 13 wherein the oligonucleotide has the nucleotide 25 sequence represented by SEQ ID NO:8.
17. The oligonucleotide of claim 13 wherein the oligonucleotide has the nucleotide sequence represented by SEQ ID NO:9. 30
18. The oligonucleotide of claim 13 wherein the oligonucleotide has the nucleotide sequence represented by SEQ ID NO:10. 33 WO 00/06777 PCT/US99/16862
19. The oligonucleotide of claim 13 wherein the oligonucleotide has the nucleotide . sequence represented by SEQ ID NO: 11. 5
20. A method of identifying an animal which possess a desired genotype indicative of the metabolic traits of fat content, growth rate, and feed consumption, the method compnsing a) obtaining a sample of genomic DNA, b) digesting the sample with Taq Ito obtain fragments, 10 c) separating the fragments obtained from the digestion, and d) identifying the presence or absence of a Taq I site at base 678 of the PCR product of the MC4R gene.
21. The method of claim 20 further comprising the step of selecting animals with the 15 desired genotype for breeding.
22. The method of claim 20 wherein the site is identifiable by fragments of 466, 225, and 76 bp when a guanine is present at base 678 and fragments of 542 and 225 bp when an adenine is present when a restriction enzyme which cuts at the same recognition site as Taq 20 Iis used.
23. The method of claim 20 wherein the step of identifying comprises detecting the Taq I site by amplification. 25
24. A kit for evaluating a sample of animal DNA comprising a reagent in a container that identifies a polymorphism in a MC4R gene.
25. The kit of claim 24 wherein the reagent is a primer that amplifies the MC4R gene or a fragment thereof 30 34 WO 00/06777 PCT/US99/16862
26. The kit of claim 24 further comprising a DNA polymerase which cleaves the MC4R gene, a forward primer, and a reverse primer, wherein the primers are capable of a amplifying a region of the MC4R gene which contains a polymorphic site. 5
27. A primer for assaying the presence of a polymorphic TaqI site in the MC4R gene wherein the primer comprises a sequence selected from the group consisting of SEQ. ID NO:6, SEQ. ID NO:7, SEQ. ID NO:8, SEQ. ID NO:9, SEQ. ID NO:10, and SEQ. ID NO:11. 10
28. A method for selecting animals for the desired traits of lower fat content, faster growth rate, or lower feed consumption comprising the steps of a) obtaining a nucleic acid sample from an animal, b) identifying a polymorphism characterized by a nucleotide position 678 of a PCR product of the MC4R gene, and 15 c) selecting the animals which have the nucleotide associated with the desired traits in position 678.
29. A method for an indirect selection for a polymorphism in MC4R wherein specific alleles of an alternative DNA marker are used to make the indirect selection wherein the 20 alternative DNA marker is a linked marker near MC4R.
30. The method of claim 29 wherein the linked marker is selected from the group consisting of S0331, BHT0433, and S0313. 25
31. A method of identifying animals which possess a desired genotype indicative of the metabolic traits of fat content, growth rate, and feed consumption, the method comprising a) determining an association between a MC4R genotype and a trait of interest by obtaining a sample of animals from a line or breed of interest, b) preparing genomic DNA from each animal in the sample, 30 c) determining the genotype of the MC4R gene, and d) calculating the association between the MC4R genotype and the trait. 35 WO 00/06777 PCT/US99/16862
32. A method of selecting animals which possess a desired MC4R genotype indicative of the metabolic traits of fat content, growth rate, and feed consumption, the method comprising 5 a) obtaining a nucleic acid sample from an animal, b) identifying the genotype of the MC4R gene of the animal, and c) selecting those animals which have the genotype associated with the desired traits. 36
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US9428798P | 1998-07-27 | 1998-07-27 | |
US60/094287 | 1998-07-27 | ||
US11618699P | 1999-01-15 | 1999-01-15 | |
US60/116186 | 1999-01-15 | ||
PCT/US1999/016862 WO2000006777A2 (en) | 1998-07-27 | 1999-07-26 | Melanocortin-4 receptor gene and use as a genetic marker for fat content, weight gain, and/or feed consumption of animals |
Publications (2)
Publication Number | Publication Date |
---|---|
AU5230199A true AU5230199A (en) | 2000-02-21 |
AU758179B2 AU758179B2 (en) | 2003-03-20 |
Family
ID=26788709
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU52301/99A Ceased AU758179B2 (en) | 1998-07-27 | 1999-07-26 | Melanocortin-4 receptor gene and use as a genetic marker for fat content, weight gain, and/or feed consumption of animals |
Country Status (10)
Country | Link |
---|---|
EP (1) | EP1100970A2 (en) |
JP (1) | JP3790102B2 (en) |
CN (1) | CN1193102C (en) |
AU (1) | AU758179B2 (en) |
BR (1) | BR9912460A (en) |
CA (1) | CA2337495C (en) |
HU (1) | HUP0102715A3 (en) |
MX (1) | MXPA01001100A (en) |
PL (1) | PL346223A1 (en) |
WO (1) | WO2000006777A2 (en) |
Families Citing this family (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2002064091A2 (en) | 2001-02-13 | 2002-08-22 | Palatin Technologies, Inc. | Melanocortin metallopeptides for treatment of sexual dysfunction |
US6803190B1 (en) | 1998-07-27 | 2004-10-12 | Iowa State University Research Foundation, Inc. | Melanocortin-4 receptor gene and use as a genetic marker for fat content, weight gain, and/or feed consumption of animals |
CZ20023261A3 (en) * | 2000-03-30 | 2003-02-12 | Iowa State University Research Foundation | Genetic markers for enhanced properties of animal meat |
WO2001079222A2 (en) * | 2000-04-12 | 2001-10-25 | Genaissance Pharmaceuticals, Inc. | Haplotypes of the mc4r gene |
US20030032791A1 (en) * | 2000-06-26 | 2003-02-13 | Alan Robertson Scott | Novel melanocortin-4 receptor sequences and screening assays to identify compounds useful in regulating animal appetite and metabolic rate |
KR100427645B1 (en) * | 2001-07-24 | 2004-04-28 | 한국생명공학연구원 | Human melanocortin-4 receptor specific antibody and the preparation method thereof |
CA2387003A1 (en) * | 2002-05-21 | 2003-11-21 | 984012 Alberta Ltd. | Method for improving efficiencies in livestock production |
WO2004061125A2 (en) | 2002-12-31 | 2004-07-22 | Mmi Genomics, Inc. | Compositions, methods and systems for inferring bovine traits |
ES2877349T3 (en) * | 2005-07-08 | 2021-11-16 | Ipsen Pharma | Melanocortin receptor ligands |
CN100591692C (en) * | 2007-08-13 | 2010-02-24 | 中国农业科学院北京畜牧兽医研究所 | Pig fat deposition related protein and encoding genes and use thereof |
EP2230944B1 (en) | 2007-11-29 | 2017-01-04 | Monsanto Technology, LLC | Meat products with increased levels of beneficial fatty acids |
CN103923997B (en) * | 2014-04-21 | 2016-09-07 | 广西壮族自治区水牛研究所 | The clone of buffalo milk production trait MC4R gene and the application as molecular labeling |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5940198A (en) * | 1995-12-22 | 1999-08-17 | U.S. Philips Corporation | Optical unit for synchronizing clock signals |
US5932779A (en) * | 1996-06-10 | 1999-08-03 | Millennium Pharmaceuticals, Inc. | Screening methods for compounds useful in the regulation of body weight |
-
1999
- 1999-07-26 HU HU0102715A patent/HUP0102715A3/en unknown
- 1999-07-26 WO PCT/US1999/016862 patent/WO2000006777A2/en active IP Right Grant
- 1999-07-26 EP EP99937474A patent/EP1100970A2/en not_active Withdrawn
- 1999-07-26 BR BR9912460-2A patent/BR9912460A/en not_active IP Right Cessation
- 1999-07-26 MX MXPA01001100A patent/MXPA01001100A/en not_active Application Discontinuation
- 1999-07-26 CA CA002337495A patent/CA2337495C/en not_active Expired - Lifetime
- 1999-07-26 JP JP2000562559A patent/JP3790102B2/en not_active Expired - Fee Related
- 1999-07-26 PL PL99346223A patent/PL346223A1/en not_active Application Discontinuation
- 1999-07-26 AU AU52301/99A patent/AU758179B2/en not_active Ceased
- 1999-07-26 CN CNB998111139A patent/CN1193102C/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
MXPA01001100A (en) | 2002-08-20 |
CN1328602A (en) | 2001-12-26 |
HUP0102715A3 (en) | 2004-10-28 |
WO2000006777A2 (en) | 2000-02-10 |
AU758179B2 (en) | 2003-03-20 |
JP3790102B2 (en) | 2006-06-28 |
CN1193102C (en) | 2005-03-16 |
HUP0102715A2 (en) | 2002-09-28 |
EP1100970A2 (en) | 2001-05-23 |
PL346223A1 (en) | 2002-01-28 |
WO2000006777A3 (en) | 2000-05-11 |
CA2337495C (en) | 2008-03-18 |
BR9912460A (en) | 2002-02-13 |
CA2337495A1 (en) | 2000-02-10 |
JP2002521068A (en) | 2002-07-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU2001249589B2 (en) | Genetic markers for improved meat characteristics in animals | |
AU2001249589A1 (en) | Genetic markers for improved meat characteristics in animals | |
AU758179B2 (en) | Melanocortin-4 receptor gene and use as a genetic marker for fat content, weight gain, and/or feed consumption of animals | |
US7244564B2 (en) | HMGA alleles and use of the same as genetic markers for growth, fatness, meat quality, and feed efficiency traits | |
US5935784A (en) | Prolactin receptor gene as a genetic marker for increased litter size in pigs | |
US6803190B1 (en) | Melanocortin-4 receptor gene and use as a genetic marker for fat content, weight gain, and/or feed consumption of animals | |
US20070037154A1 (en) | Fine mapping of chromosome 17 quantitative trait loci and use of same for marker assisted selection | |
US20050059021A1 (en) | Insulin-like growth factor-1 receptor (IGF-1R) polymorphic alleles and use of the same to identify DNA markers for reproductive longevity | |
US6458531B1 (en) | Leptin receptor gene as a genetic marker for leanness in pigs | |
US7074562B2 (en) | Ghrelin alleles and use of the same for genetically typing animals | |
US20110263435A1 (en) | Genetic markers for boar taint | |
US20040259127A1 (en) | Approaches to identifying genetic traits in animals | |
Liu et al. | Association of MC4R gene variants with carcass and meat quality traits in Qinchuan cattle | |
WO2006099055A2 (en) | Sequence, polymorphisms, and marker test technology for disease resistance and growth (nfkb1) |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FGA | Letters patent sealed or granted (standard patent) |